Announced Thu, 9 Apr · 10:45 IST
RTA Certificate for Q4 FY2026 under SEBI Regulation 74(5)
Compliance View source PDF
GLAXO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
+1.8%1-day move
₹2350.10
prior close
₹2361.10
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.1+0.0+0.0+0.3+1.8+2.5+2.4+3.0+4.3+3.3-0.8+3.6-6.4+3.4
Up moveDown movePending
AI summary
GlaxoSmithKline Pharmaceuticals has submitted a certificate from its Registrar and Share Transfer Agent, Kfin Technologies Limited, for the quarter ended 31st March 2026. As per SEBI Regulation 74(5), Kfin confirms that securities received for dematerialisation during the quarter were processed and confirmed to depositories, and that physical share certificates received were mutilated and cancelled within 30 days, with the depository's name substituted in the register of members.
Likely market impact
Routine quarterly compliance filing. No material impact on company financials or shareholders.